Kim L.R. Brouwer

Biography

Kim Brouwer, PharmD, PhD, is Associate Dean for Research and Graduate Education, UNC Eshelman School of Pharmacy, and Kenan Distinguished Professor in the School of Pharmacy and Curriculum in Toxicology at the University of North Carolina at Chapel Hill. Dr. Brouwer’s research program, funded by NIH since 1991, focuses on hepatobiliary drug disposition, hepatic transport proteins, and novel approaches to predict drug interactions and hepatotoxicity. She was founding Director of the UNC Pharmacokinetics/Pharmacodynamics Fellowship Program, and is Co-PI of NIH-funded Postdoctoral T32 Training Programs in Adult and Pediatric Clinical Pharmacology. She has mentored more than 100 trainees including clinical pharmacology fellows, postdoctoral scholars and PhD students, and authored more than 250 publications. Dr. Brouwer is co-inventor of B-CLEAR® technology and a company co-founder. She is a member of the International Transporter Consortium Steering Committee, and has served as a member of the NIH Pharmacology Study Section. Dr. Brouwer has received many prestigious awards for her outstanding contributions as a leading academic researcher including AAPS Fellow, PhRMA Foundation Award in Excellence in Pharmaceutics, ASCPT-FDA Abrams Award, UNC Inventor of the Year, AACP Volwiler Research Achievement Award, an honorary doctorate from the University of Eastern Finland, and the 2022 ACCP Distinguished Investigator Award.